Identification of GPR55 as a lysophosphatidylinositol receptor

被引:371
作者
Oka, Saori [1 ]
Nakajima, Keisuke [1 ]
Yamashita, Atsushi [1 ]
Kishimoto, Seishi [1 ]
Sugiura, Takayuki [1 ]
机构
[1] Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 2290195, Japan
关键词
lysophosphatidylinositol; G protein-coupled receptor; GPR55; lipid mediator; bioactive lipid; extracellular signal-regulated kinase; Ca2+ transient; HEK293; cell;
D O I
10.1016/j.bbrc.2007.08.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GPR55 is an orphan G protein-coupled receptor. In this study, we explored a possible endogenous ligand for GPR55 using HEK293 cells which expressed GPR55. We found that lysophosphatidylinositol induced rapid phosphorylation of the extracellular signal-regulated kinase in transiently or stably GPR55-expressing cells. On the other hand, lysophosphatidylinositol did not induce phosphorylation of the extracellular signal-regulated kinase in vector-transfected cells. Lysophosphatidic acid and sphingosine 1-phosphate also induced phosphorylation of the extracellular signal-regulated kinase in GPR55-expressing cells. However, these lipid phosphoric acids elicited similar responses in vector-transfected cells. Various types of other lysolipids as well as the cannabinoid receptor ligands did not induce phosphorylation of the extracellular signal-regulated kinase. We also found that lysophosphatidylinositol elicited a rapid Ca2+ transient in GPR55-expressing cells. Lysophosphatidylinositol also stimulated the binding of GTP gamma S to the GPR55-expressing cell membranes. These results strongly suggest that GPR55 is a specific and functional receptor for lysophosphatidylinositol. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:928 / 934
页数:7
相关论文
共 21 条
[1]   In silico patent searching reveals a new cannabinoid receptor [J].
Baker, D ;
Pryce, G ;
Davies, WL ;
Hiley, CR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (01) :1-4
[2]   LYSOPHOSPHATIDYLINOSITOL - A POTENTIAL MEDIATOR OF 1,25-DIHYDROXYVITAMIN-D-INDUCED INCREMENTS IN HEPATOCYTE CYTOSOLIC CALCIUM [J].
BARAN, DT ;
KELLY, AM .
ENDOCRINOLOGY, 1988, 122 (03) :930-934
[3]  
Breivogel CS, 1997, J PHARMACOL EXP THER, V282, P1632
[4]  
Brown AJ, 2001, GlaxoSmithKline Patent, Patent No. [WO0186305, 0186305]
[5]   Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols [J].
Corda, D ;
Iurisci, C ;
Berrie, CP .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1582 (1-3) :52-69
[6]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[7]  
Drmota E, 2004, Patent, Patent No. [WO2004074844, 2004074844]
[8]  
FALASCA M, 1995, ONCOGENE, V10, P2113
[9]   ELEVATED LEVELS AND MITOGENIC ACTIVITY OF LYSOPHOSPHATIDYLINOSITOL IN K-RAS-TRANSFORMED EPITHELIAL-CELLS [J].
FALASCA, M ;
CORDA, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 221 (01) :383-389
[10]   Lysophospholipid receptors: Signaling and biology [J].
Ishii, I ;
Fukushima, N ;
Ye, XQ ;
Chun, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :321-354